Research progress of treating ulcerative colitis and colon cancer by using oral colon targeted drug delivery system based on polymer micelles
{{output}}
Ulcerative colitis (UC) and colon cancer (CC) represent significant global health burdens. Current first-line chemotherapeutic agents, including capecitabine, oxaliplatin, and irinotecan, face two principal limitations: poor tumor specificity and dose-limiting... ...
